The name of the game is volume. The more volume a drug company has with a particular PBM, and the greater the drug company's market share, the better the potential deal that the drug company can offer as an inducement to disfavor rival drugs.
Warren discusses how PBMs create incentives that favor larger drug companies over competitors.
Share & report
More from Elizabeth Warren
This could mean that independent retailers are at a disadvantage when it comes to negotiating with suppliers.
This is particularly concerning given that more than half of parents ‘plan to sacrifice necessities, such as groceries,’ because of rising prices for back-to-school shopping.
Dick’s and Foot Locker currently compete with each other and with independent retailers to secure deals with suppliers.
this looks a lot, smells a lot, sounds a lot like you’re purchasing favors from the President of the United States and that’s a serious problem.
Other voices in this conversation
